Publications
328
Citations
31,563
Est. group size
~31
Recurring co-author estimate
Active years
27
Publishing since 2000
Typically publishes in teams of ~16 · 1% small-team papers (≤3 authors) · across 18 venues
- Figure S3 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Data from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Figure S1 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Figure S5 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Key Resources Table 1 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Figure S2 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Figure S6 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
2026
- Abstract 1352: Transcriptional and post-translational regulation of B7-H4.
Cancer Research · 2026
- Palmitoylation prevents B7-H4 lysosomal degradation sustaining tumor immune evasion
Nature Communications · 2025
- Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance 2475
The Journal of Immunology · 2025
- Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance 2251
The Journal of Immunology · 2025
- Snail1 retains CD8+T cell effector function in tumor immunity 2104
The Journal of Immunology · 2025
- Regulatory T Cells in Tumor Immunity
Elsevier eBooks · 2025
- Microbiota-dependent activation of CD4 <sup>+</sup> T cells induces CTLA-4 blockade–associated colitis via Fcγ receptors
Science · 2024
- Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance
Cancer Cell · 2024
- The Journal of Immunology×18
- Cancer Research×6
- Nature×4
- Cancer Discovery×4
- Cancer Cell×4
- Weiping Zou
Medicine · University of Michigan
- Shuang Wei
Medicine · University of Michigan
- Andreas Wieland
Medicine · The Ohio State University
- Hazem E. Ghoneim
Medicine · The Ohio State University
- Nandini Acharya
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile